These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 220875)

  • 41. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex steroids and cancer.
    Gambrell RD
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The progestational activity of different gestagens used for human contraception in the beagle bitch.
    Beier S; Haase F; Kosub B; Düsterberg B; Elger W
    Contraception; 1979 Dec; 20(6):533-48. PubMed ID: 94000
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methodological issues in epidemiologic studies of endometrial cancer and exogenous estrogen.
    Hulka BS; Hogue CJ; Greenberg BG
    Am J Epidemiol; 1978 Apr; 107(4):267-76. PubMed ID: 645695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogenic activity in women receiving an injectable progestogen for contraception.
    Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
    Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
    Brooks PG; Serden SP; Davos I
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoplasia of the female reproductive tract: effects of hormone therapy.
    Archer DF
    Endocrine; 2004 Aug; 24(3):259-63. PubMed ID: 15542895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.
    Heston WE; Vlahakis G; Desmukes B
    J Natl Cancer Inst; 1973 Jul; 51(1):209-24. PubMed ID: 4352748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The varying effects of progestins on lipid levels and cardiovascular disease.
    La Rosa JC
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1621-9. PubMed ID: 3132043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL; Felix JC
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
    Laatikainen T; Nieminen U; Adlercreutz H
    Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risks and benefits of long-term treatment with estrogens.
    Mack TM; Ross RK
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced regeneration of endometrium following curettage for abortion: a comparative study.
    Farhi J; Bar-Hava I; Homburg R; Dicker D; Ben-Rafael Z
    Hum Reprod; 1993 Jul; 8(7):1143-4. PubMed ID: 8408501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The protective role of progesterone in the prevention of endometrial cancer.
    Greenblatt RB; Gambrell RD; Stoddard LD
    Pathol Res Pract; 1982 Aug; 174(3):297-318. PubMed ID: 7145772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contraceptive and endometrial effects of medroxyprogesterone acetate.
    Lee RA
    Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogens, progestogens and endometrial cancer.
    Gambrell RD
    J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.